Pluri (PLUR) Asset Utilization Ratio (2012 - 2025)

Pluri (PLUR) reported Asset Utilization Ratio of 0.04 for Q4 2025, up 103.75% year-over-year from 0.02 in Q4 2024, and up 13.69% quarter-over-quarter from 0.04 in Q3 2025.

Pluri (PLUR) Asset Utilization Ratio (2012 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2025.

  • Asset Utilization Ratio for Q4 2025 came in at 0.04, up 103.75% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.04 (up 103.75% YoY), and the FY2025 annual result was 0.03, up 373.29% from the prior year.
  • Asset Utilization Ratio climbed to 0.04 in Q4 2025 per PLUR's latest filing, from 0.04 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.04 in Q4 2025 and troughed at 0.0 in Q1 2023.
  • A 4-year average of 0.01 and a median of 0.01 in 2023 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio fell 5.49% in 2023, then surged 308.88% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then jumped by 53.62% to 0.01 in 2023, then surged by 146.64% to 0.02 in 2024, then surged by 103.75% to 0.04 in 2025.
  • Business Quant data shows PLUR's Asset Utilization Ratio at 0.04 in Q4 2025, 0.04 in Q3 2025, and 0.04 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 0.55
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 1,422.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.47
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 0.04

Historic Data

Download Data
DateValue
Dec 31, 2025 0.04
Sep 30, 2025 0.04
Jun 30, 2025 0.04
Mar 31, 2025 0.03
Dec 31, 2024 0.02
Sep 30, 2024 0.02
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.00
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Jun 30, 2019 0.00